Evidence map›Paper›PMID 34873878›Full record

ArticleESC heart failure2022

Levosimendan for VA-ECMO weaning: the silver lining.

Rasha Kaddoura, Mohamed Izham Mohamed Ibrahim, Amr Omar

Open access · goldAbstract readLetterComment
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rasha KaddouraDepartment of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0003-2613-9759
Mohamed Izham Mohamed IbrahimMedical and Health Sciences Office, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Amr OmarDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QAQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Extracorporeal Membrane OxygenationHumansShock, CardiogenicSimendanSimendan

Identifiers

PMID34873878
PMCPMC8788139
OpenAlexW4200380308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.